Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia

Published:2011-12-19 Issue:1 Volume:59 Page:83-89
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Morishita Naoto,Tsukahara Hirokazu,Chayama Kosuke,Ishida Toshiaki,Washio Kana,Miyamura Takako,Yamashita Nobuko,Oda Megumi,Morishima Tsuneo

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference33 articles.

1. Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital;Pui;Blood,2004

2. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia;Moghrabi;Blood,2007

3. Childhood acute lymphoblastic leukaemia and relapse;Gaynon;Br J Haematol,2005

4. High-risk childhood acute lymphoblastic leukemia in China: Factors influencing the treatment and outcome;Luo;Pediatr Blood Cancer,2009

5. The Akt-mTOR tango and its relevance to cancer;Hay;Cancer Cell,2005

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and cellular mechanisms of chemoresistance in paediatric pre–B cell acute lymphoblastic leukaemia;Cancer and Metastasis Reviews;2024-08-05

2. SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model;Cells;2023-07-06

3. In vitro simulation of the acute lymphoblastic leukemia niche: a critical view on the optimal approximation for drug testing;Journal of Leukocyte Biology;2023-04-11

4. Association between Dysfunction of the Nucleolar Stress Response and Multidrug Resistance in Pediatric Acute Lymphoblastic Leukemia;Cancers;2022-10-19

5. Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development;Scientific Reports;2022-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3